Skip to main content
. 2021 May 10;4(5):e218055. doi: 10.1001/jamanetworkopen.2021.8055

Table 1. Characteristics of the Study Population of 301 327 Patients.

Characteristic No. (%)a
Age, mean (SD), y 75.1 (7.3)
Cancer type
Breast 78 736 (26.1)
Colorectal 51 385 (17.0)
Lung 95 635 (31.9)
Prostate 75 571 (25.0)
Sex
Male 149 485 (49.6)
Female 151 842 (50.4)
Race/ethnicity
White 241 232 (80.0)
Black 26 650 (8.8)
Hispanic 15 991 (5.3)
Asian/Pacific Islander 13 537 (4.5)
Otherb 3917 (1.3)
Marital status
Married 155 337 (52.0)
Single/divorced/separated/widowed 122 485 (40.6)
Unknown 23 505 (7.8)
Year of diagnosis
2011 64 185 (21.3)
2012 61 478 (20.4)
2013 59 317 (19.7)
2014 57 960 (19.2)
2015 58 387 (19.4)
Charlson Comorbidity Index
0 116 382 (38.6)
1 73 049 (24.4)
2 43 857 (14.2)
≥3 68 039 (22.6)
SEER registry sites
San Francisco-Oakland/San Jose-Monterey 17 804 (5.9)
Connecticut 16 249 (5.4)
Detroit 18 429 (6.1)
Hawaii 3181 (1.0)
Iowa 17 778 (5.9)
New Mexico 5877 (2.0)
Seattle-Puget Sound 18 135 (6.0)
Utah 5710 (1.9
Los Angeles 17 340 (5.8)
Greater California 55 755 (18.5)
Kentucky 23 668 (7.9)
Louisiana 19 974 (6.7)
New Jersey 45 134 (15.0)
Georgia 36 293 (12.0)
Cancer-directed surgery within 6 mo
No 165 129 (54.8)
Yes 136 198 (45.2)
Chemotherapy within 6 mo
No 180 885 (60.0)
Yes 120 442 (40.0)
Radiation within 6 mo
No 222 558 (73.8)
Yes 78 769 (26.2)
a

Percentages may not total 100 because of rounding.

b

Other racial/ethnic groups include 1119 American Indian/Alaska Native patients and 2798 patients with unknown race/ethnicity.